The early days of the US International Development Finance Corporation (DFC) have been defined by a mixed record, and its health-focused investments are no exception. In the face of competing foreign (and even domestic) policy priorities under the Trump Administration and pandemic-related shifts in the broader development landscape, the agency has struggled to build a solid pipeline of projects in lower-income markets and systematically articulate a strong development rationale for its financing.
CGD Policy Blogs
Humanitarian donor governments today spend roughly $25 billion every year, and approximately two-thirds of this is channeled through UN agencies and the international Red Cross/Red Crescent Movement.
Dear President Biden and Congress: Time for US to Lead Response to the Growing COVID-19 Global Vaccine Crisis
Today we joined colleagues from CSIS, Duke University, and the COVID Collective in an open letter to the Biden Administration and US Congress with a clear message: to hasten the end of the COVID-19 global pandemic, American leadership is required to ensure universal global access to high-quality and safe vaccines, support rapid vaccine distribution and administration, and build a sustainable global network of vaccine manufacturing capacity. Vaccines offer an exit route out of the pandemic – but only if they reach a critical mass of people in need across continents, socioeconomic strata, and marginalized populations.
The US has backed a request—originally proposed by South Africa and India and now supported by over 100 countries—to temporarily waive international intellectual property protections on COVID vaccines & other health technologies.
Enough. We cannot continue business as usual. Until this crisis is over—and over everywhere—exiting the COVID-19 mass casualty event must be the singular focus of the international community.
Biden Wants to Eliminate Lead Poisoning in American Children. We Propose an Even More Ambitious Goal: Global Eradication.
We applaud the Biden Administration's effort to address lead poisoning in the US. But we suggest Biden adopt an even more ambitious goal: not just national elimination, but global eradication of lead poisoning, especially in children. A global eradication campaign—modelled loosely on prior and ongoing global efforts to eradicate smallpox, polio, and guinea worm, mixed with inspiration from the WHO’s Framework Convention on Tobacco Control—would offer a tremendous contribution to global welfare, economic growth, and even world peace. An American-led effort to eliminate lead poisoning globally could be an international moonshot elevating the Biden administration’s international statue and legacy.
Bridging the Gap between Health Financing and Family Planning: How to Effectively Advocate for Contraception in UHC
Drawing from a workshop in February 2020, the authors offer an evidence review and proposed approach to inform policymakers as they evaluate contraception for inclusion in health benefits packages.
Monday Morning Vaccine Breakthrough: Terrific News for the West, but in LMICs Terms and Conditions Apply
This morning, America (and much of the world) woke up to a snippet of terrific news: Pfizer and BioNTech announced their SARS-CoV2 vaccine candidate showed 90 percent efficacy. But for policymakers in low- and middle-income countries, today’s news offers limited cause for celebration—and the Pfizer/BioNTech results may even lengthen the timeline for eventual LMIC access.
In this blog, we review the good and the bad about where the world now stands in efforts to bringing a vaccine to market, from the perspective of payers, national governments, and country coalitions, as well as development partners.
The global race to develop a COVID-19 vaccine is far from conventional. An effective vaccine would offer one of the few credible exit paths from the world’s worst public health and economic crisis in recent history. Is a pull for R&D essential or optional?